These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 207959

  • 21. [Treatment of primary hyperlipoproteinemias. Comparison of N 041 with clofibrate].
    Gaertner U, Johannes KJ.
    MMW Munch Med Wochenschr; 1976 Sep 03; 118(36):1127-30. PubMed ID: 184377
    [Abstract] [Full Text] [Related]

  • 22. The treatment of hyperlipoproteinaemia with gemfibrozil compared with placebo and clofibrate.
    Nye ER, Sutherland WH, Temple Wa.
    N Z Med J; 1980 Nov 12; 92(671):345-9. PubMed ID: 6935550
    [Abstract] [Full Text] [Related]

  • 23. [Dyslipidemic patients with coronary cardiopathy. Effect of different doses of OMEGA-3 fatty acids on serum lipids and lipoproteins].
    Arteaga A, Villanueva CL, Skorin C, Guasch V, Solís de Ovando F, Velasco N, Acosta AM, Leighton F.
    Rev Med Chil; 1993 Jun 12; 121(6):618-25. PubMed ID: 8278696
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effect of moderate isocaloric modification of dietary carbohydrate on high-density lipoprotein composition and apolipoprotein A-1 turnover in humans.
    Zimmerman J, Eisenberg S, Kaufmann NA, Fainaru M, Oschry Y, Friedlander Y, Stein Y.
    Isr J Med Sci; 1986 Feb 12; 22(2):95-104. PubMed ID: 3949491
    [Abstract] [Full Text] [Related]

  • 26. Replacement of carbohydrate by protein in a conventional-fat diet reduces cholesterol and triglyceride concentrations in healthy normolipidemic subjects.
    Wolfe BM, Piché LA.
    Clin Invest Med; 1999 Aug 12; 22(4):140-8. PubMed ID: 10497712
    [Abstract] [Full Text] [Related]

  • 27. [Fenofibrate: hypolipaemic activity and safety in long-term treatment. Effects on HDL, LDL, VLDL and apoprotein B in short-term treatment (author's transl)].
    Rouffy J, Sauvanet JP, Chanu B, Bakir R, Goy-Loeper J, Saya C, Pinaroli F.
    Nouv Presse Med; 1980 Dec 22; 9(49):3747-51. PubMed ID: 7208341
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Combination of clofibrate and phenformin in the treatment of endogenous hypertriglyceridaemia (author's transl)].
    Vogelberg KH.
    Dtsch Med Wochenschr; 1976 Dec 17; 101(51):1868-71. PubMed ID: 1001205
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Effect of etofylline clofibrate on the composition of lipoproteins in hyperlipidaemia type IIb and IV (author's transl)].
    Ditschuneit HH, Hutt V, Klör HU, Ditschuneit H.
    Arzneimittelforschung; 1980 Dec 17; 30(11b):2063-7. PubMed ID: 7194061
    [Abstract] [Full Text] [Related]

  • 32. [Therapy of hyperlipoproteinemia type II with Xantinol-nicotinate (author's transl)].
    Haacke H, Parwaresch MR, Mäder C.
    Med Klin; 1977 Jul 08; 72(27):1183-7. PubMed ID: 196168
    [Abstract] [Full Text] [Related]

  • 33. [Changes in serum lipoproteins in cerebrovascular disease (author's transl)].
    Bruck J, Fischer M, Tschabitscher H.
    Wien Klin Wochenschr; 1981 Oct 16; 93(19):604-9. PubMed ID: 7324470
    [Abstract] [Full Text] [Related]

  • 34. [The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types].
    Noseda G, Fragiacomo C, Weidmann P, Bachmann C.
    Schweiz Med Wochenschr; 1980 Dec 06; 110(49):1875-7. PubMed ID: 7455660
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Hyperlipoproteinemia type IIa. Serum lipoprotein pattern as influenced by diet and clofibrate].
    Mertz DP, Suermann I, Loewer H, Schmidt GG.
    MMW Munch Med Wochenschr; 1979 Jun 08; 121(23):791-2. PubMed ID: 223044
    [No Abstract] [Full Text] [Related]

  • 37. [Effect of diet and drug therapy on the level of high density lipoprotein cholesterol in patients with primary hyperlipoproteinemia].
    Padosh D, Kustosh D, Puchok I, Dem'ianova N, Audikovski M.
    Klin Med (Mosk); 1981 Sep 08; 59(9):45-8. PubMed ID: 7311430
    [No Abstract] [Full Text] [Related]

  • 38. [The relationship of cholesterol (CHO) and triglycerides (TG) in VLDL, LDL, and VLDL subfractions by agarose gel electrophoresis, using CHO and TG dual staining (AG-CHO, TG staining)].
    Miyake N, Iizuka K.
    Rinsho Byori; 2002 Jun 08; 50(6):605-12. PubMed ID: 12166081
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Atilipidemic drugs. Part 5: Evaluation of the hypolipidemic effect of LF 178 in 191 patients affected by the atherogenic form of endogenous hyperlipoproteinemia (types IIa, IIb and IV).
    Rouffy J, Dreux C, Goussault Y, Dakkak R, Renson FJ.
    Arzneimittelforschung; 1976 Jun 08; 26(5):901-6. PubMed ID: 183788
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.